nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—Venoocclusive disease—Carmustine—malignant glioma	0.0539	0.0946	CcSEcCtD
Clofarabine—Adenosine monophosphate—PIM1—malignant glioma	0.014	1	CrCbGaD
Clofarabine—RRM2—embryo—malignant glioma	0.0139	0.0798	CbGeAlD
Clofarabine—POLA1—retina—malignant glioma	0.0129	0.0738	CbGeAlD
Clofarabine—Lymphopenia—Temozolomide—malignant glioma	0.0117	0.0206	CcSEcCtD
Clofarabine—Nephropathy toxic—Carmustine—malignant glioma	0.0108	0.019	CcSEcCtD
Clofarabine—Skin hyperpigmentation—Carmustine—malignant glioma	0.0104	0.0183	CcSEcCtD
Clofarabine—Febrile neutropenia—Carmustine—malignant glioma	0.0103	0.0181	CcSEcCtD
Clofarabine—RRM1—retina—malignant glioma	0.0102	0.0586	CbGeAlD
Clofarabine—Febrile neutropenia—Temozolomide—malignant glioma	0.00998	0.0175	CcSEcCtD
Clofarabine—Oral candidiasis—Carmustine—malignant glioma	0.00978	0.0172	CcSEcCtD
Clofarabine—Oral candidiasis—Temozolomide—malignant glioma	0.00946	0.0166	CcSEcCtD
Clofarabine—RRM1—telencephalon—malignant glioma	0.00942	0.0539	CbGeAlD
Clofarabine—Cyst—Carmustine—malignant glioma	0.0093	0.0163	CcSEcCtD
Clofarabine—DCK—embryo—malignant glioma	0.009	0.0515	CbGeAlD
Clofarabine—Menorrhagia—Temozolomide—malignant glioma	0.00812	0.0142	CcSEcCtD
Clofarabine—Hepatotoxicity—Carmustine—malignant glioma	0.00805	0.0141	CcSEcCtD
Clofarabine—Herpes zoster—Temozolomide—malignant glioma	0.00798	0.014	CcSEcCtD
Clofarabine—DCK—retina—malignant glioma	0.00795	0.0455	CbGeAlD
Clofarabine—Necrosis—Carmustine—malignant glioma	0.00792	0.0139	CcSEcCtD
Clofarabine—Hepatotoxicity—Temozolomide—malignant glioma	0.00778	0.0137	CcSEcCtD
Clofarabine—RRM1—medulla oblongata—malignant glioma	0.0074	0.0424	CbGeAlD
Clofarabine—DCK—telencephalon—malignant glioma	0.00732	0.0419	CbGeAlD
Clofarabine—Petechiae—Temozolomide—malignant glioma	0.0073	0.0128	CcSEcCtD
Clofarabine—Liver injury—Temozolomide—malignant glioma	0.00714	0.0125	CcSEcCtD
Clofarabine—RRM1—midbrain—malignant glioma	0.00676	0.0387	CbGeAlD
Clofarabine—Viral infection—Temozolomide—malignant glioma	0.00665	0.0117	CcSEcCtD
Clofarabine—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00661	0.0116	CcSEcCtD
Clofarabine—RRM1—spinal cord—malignant glioma	0.0066	0.0378	CbGeAlD
Clofarabine—POLA1—cerebellum—malignant glioma	0.00659	0.0377	CbGeAlD
Clofarabine—Herpes simplex—Temozolomide—malignant glioma	0.00652	0.0114	CcSEcCtD
Clofarabine—RRM2—central nervous system—malignant glioma	0.00644	0.0369	CbGeAlD
Clofarabine—Hearing impaired—Temozolomide—malignant glioma	0.00631	0.0111	CcSEcCtD
Clofarabine—Respiratory failure—Temozolomide—malignant glioma	0.00612	0.0107	CcSEcCtD
Clofarabine—Candida infection—Carmustine—malignant glioma	0.00593	0.0104	CcSEcCtD
Clofarabine—Skin exfoliation—Carmustine—malignant glioma	0.00593	0.0104	CcSEcCtD
Clofarabine—DCK—medulla oblongata—malignant glioma	0.00575	0.0329	CbGeAlD
Clofarabine—Candida infection—Temozolomide—malignant glioma	0.00573	0.0101	CcSEcCtD
Clofarabine—Skin exfoliation—Temozolomide—malignant glioma	0.00573	0.0101	CcSEcCtD
Clofarabine—Neoplasm—Carmustine—malignant glioma	0.00562	0.00986	CcSEcCtD
Clofarabine—Neoplasm—Temozolomide—malignant glioma	0.00543	0.00953	CcSEcCtD
Clofarabine—Sepsis—Carmustine—malignant glioma	0.00539	0.00946	CcSEcCtD
Clofarabine—POLA1—brain—malignant glioma	0.00535	0.0306	CbGeAlD
Clofarabine—RRM1—central nervous system—malignant glioma	0.00535	0.0306	CbGeAlD
Clofarabine—DCK—midbrain—malignant glioma	0.00525	0.0301	CbGeAlD
Clofarabine—RRM1—cerebellum—malignant glioma	0.00523	0.0299	CbGeAlD
Clofarabine—DCK—spinal cord—malignant glioma	0.00513	0.0293	CbGeAlD
Clofarabine—RRM2—brain—malignant glioma	0.00512	0.0293	CbGeAlD
Clofarabine—Deafness—Temozolomide—malignant glioma	0.00487	0.00855	CcSEcCtD
Clofarabine—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00451	0.00792	CcSEcCtD
Clofarabine—RRM1—brain—malignant glioma	0.00425	0.0243	CbGeAlD
Clofarabine—DCK—central nervous system—malignant glioma	0.00416	0.0238	CbGeAlD
Clofarabine—ABCG2—telencephalon—malignant glioma	0.00408	0.0234	CbGeAlD
Clofarabine—DCK—cerebellum—malignant glioma	0.00406	0.0233	CbGeAlD
Clofarabine—Dehydration—Temozolomide—malignant glioma	0.00405	0.00712	CcSEcCtD
Clofarabine—Dry skin—Temozolomide—malignant glioma	0.004	0.00701	CcSEcCtD
Clofarabine—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00393	0.00689	CcSEcCtD
Clofarabine—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00393	0.00689	CcSEcCtD
Clofarabine—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00385	0.00675	CcSEcCtD
Clofarabine—Pancytopenia—Carmustine—malignant glioma	0.0037	0.0065	CcSEcCtD
Clofarabine—Neutropenia—Carmustine—malignant glioma	0.00365	0.0064	CcSEcCtD
Clofarabine—Pancytopenia—Temozolomide—malignant glioma	0.00358	0.00628	CcSEcCtD
Clofarabine—Neutropenia—Temozolomide—malignant glioma	0.00352	0.00618	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Temozolomide—malignant glioma	0.0035	0.00615	CcSEcCtD
Clofarabine—Pneumonia—Carmustine—malignant glioma	0.0035	0.00614	CcSEcCtD
Clofarabine—Renal failure—Carmustine—malignant glioma	0.00342	0.006	CcSEcCtD
Clofarabine—Weight decreased—Temozolomide—malignant glioma	0.00341	0.00598	CcSEcCtD
Clofarabine—Neuropathy peripheral—Carmustine—malignant glioma	0.00341	0.00598	CcSEcCtD
Clofarabine—Stomatitis—Carmustine—malignant glioma	0.00339	0.00595	CcSEcCtD
Clofarabine—Pneumonia—Temozolomide—malignant glioma	0.00338	0.00593	CcSEcCtD
Clofarabine—Infestation—Temozolomide—malignant glioma	0.00336	0.0059	CcSEcCtD
Clofarabine—Infestation NOS—Temozolomide—malignant glioma	0.00336	0.0059	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00333	0.00585	CcSEcCtD
Clofarabine—DCK—brain—malignant glioma	0.0033	0.0189	CbGeAlD
Clofarabine—Neuropathy peripheral—Temozolomide—malignant glioma	0.00329	0.00578	CcSEcCtD
Clofarabine—Stomatitis—Temozolomide—malignant glioma	0.00328	0.00575	CcSEcCtD
Clofarabine—ABCG2—medulla oblongata—malignant glioma	0.00321	0.0184	CbGeAlD
Clofarabine—Hepatobiliary disease—Temozolomide—malignant glioma	0.00318	0.00558	CcSEcCtD
Clofarabine—Sinusitis—Temozolomide—malignant glioma	0.00315	0.00553	CcSEcCtD
Clofarabine—Haemoglobin—Carmustine—malignant glioma	0.00314	0.00551	CcSEcCtD
Clofarabine—Haemorrhage—Carmustine—malignant glioma	0.00312	0.00548	CcSEcCtD
Clofarabine—Oedema peripheral—Carmustine—malignant glioma	0.00307	0.0054	CcSEcCtD
Clofarabine—Connective tissue disorder—Carmustine—malignant glioma	0.00307	0.00538	CcSEcCtD
Clofarabine—Haemoglobin—Temozolomide—malignant glioma	0.00303	0.00532	CcSEcCtD
Clofarabine—Haemorrhage—Temozolomide—malignant glioma	0.00302	0.00529	CcSEcCtD
Clofarabine—Urinary tract disorder—Temozolomide—malignant glioma	0.00298	0.00523	CcSEcCtD
Clofarabine—Oedema peripheral—Temozolomide—malignant glioma	0.00297	0.00521	CcSEcCtD
Clofarabine—Connective tissue disorder—Temozolomide—malignant glioma	0.00296	0.0052	CcSEcCtD
Clofarabine—Urethral disorder—Temozolomide—malignant glioma	0.00296	0.00519	CcSEcCtD
Clofarabine—ABCG2—midbrain—malignant glioma	0.00293	0.0168	CbGeAlD
Clofarabine—Flushing—Carmustine—malignant glioma	0.0029	0.00508	CcSEcCtD
Clofarabine—ABCG2—spinal cord—malignant glioma	0.00286	0.0164	CbGeAlD
Clofarabine—Erythema multiforme—Temozolomide—malignant glioma	0.00285	0.005	CcSEcCtD
Clofarabine—Flushing—Temozolomide—malignant glioma	0.0028	0.00491	CcSEcCtD
Clofarabine—Cardiac disorder—Temozolomide—malignant glioma	0.0028	0.00491	CcSEcCtD
Clofarabine—Alopecia—Carmustine—malignant glioma	0.00276	0.00484	CcSEcCtD
Clofarabine—Angiopathy—Temozolomide—malignant glioma	0.00274	0.0048	CcSEcCtD
Clofarabine—Mental disorder—Carmustine—malignant glioma	0.00273	0.0048	CcSEcCtD
Clofarabine—Immune system disorder—Temozolomide—malignant glioma	0.00272	0.00478	CcSEcCtD
Clofarabine—Mediastinal disorder—Temozolomide—malignant glioma	0.00272	0.00477	CcSEcCtD
Clofarabine—Erythema—Carmustine—malignant glioma	0.00272	0.00477	CcSEcCtD
Clofarabine—Malnutrition—Carmustine—malignant glioma	0.00272	0.00477	CcSEcCtD
Clofarabine—Chills—Temozolomide—malignant glioma	0.00271	0.00475	CcSEcCtD
Clofarabine—Alopecia—Temozolomide—malignant glioma	0.00267	0.00468	CcSEcCtD
Clofarabine—Mental disorder—Temozolomide—malignant glioma	0.00264	0.00464	CcSEcCtD
Clofarabine—Back pain—Carmustine—malignant glioma	0.00263	0.00461	CcSEcCtD
Clofarabine—Malnutrition—Temozolomide—malignant glioma	0.00263	0.00461	CcSEcCtD
Clofarabine—Erythema—Temozolomide—malignant glioma	0.00263	0.00461	CcSEcCtD
Clofarabine—Tremor—Carmustine—malignant glioma	0.00255	0.00447	CcSEcCtD
Clofarabine—Back pain—Temozolomide—malignant glioma	0.00254	0.00446	CcSEcCtD
Clofarabine—Anaemia—Carmustine—malignant glioma	0.00251	0.00441	CcSEcCtD
Clofarabine—Agitation—Carmustine—malignant glioma	0.0025	0.00438	CcSEcCtD
Clofarabine—Tremor—Temozolomide—malignant glioma	0.00246	0.00432	CcSEcCtD
Clofarabine—Leukopenia—Carmustine—malignant glioma	0.00243	0.00427	CcSEcCtD
Clofarabine—Anaemia—Temozolomide—malignant glioma	0.00243	0.00426	CcSEcCtD
Clofarabine—Agitation—Temozolomide—malignant glioma	0.00241	0.00423	CcSEcCtD
Clofarabine—Leukopenia—Temozolomide—malignant glioma	0.00235	0.00412	CcSEcCtD
Clofarabine—Hypertension—Carmustine—malignant glioma	0.00235	0.00412	CcSEcCtD
Clofarabine—Myalgia—Carmustine—malignant glioma	0.00231	0.00406	CcSEcCtD
Clofarabine—Anxiety—Carmustine—malignant glioma	0.00231	0.00405	CcSEcCtD
Clofarabine—Cough—Temozolomide—malignant glioma	0.00229	0.00402	CcSEcCtD
Clofarabine—ABCG2—cerebellum—malignant glioma	0.00227	0.013	CbGeAlD
Clofarabine—Hypertension—Temozolomide—malignant glioma	0.00227	0.00398	CcSEcCtD
Clofarabine—Myalgia—Temozolomide—malignant glioma	0.00224	0.00392	CcSEcCtD
Clofarabine—Arthralgia—Temozolomide—malignant glioma	0.00224	0.00392	CcSEcCtD
Clofarabine—Anxiety—Temozolomide—malignant glioma	0.00223	0.00391	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00222	0.0039	CcSEcCtD
Clofarabine—Oedema—Carmustine—malignant glioma	0.00222	0.00389	CcSEcCtD
Clofarabine—Infection—Carmustine—malignant glioma	0.0022	0.00387	CcSEcCtD
Clofarabine—Thrombocytopenia—Carmustine—malignant glioma	0.00217	0.00381	CcSEcCtD
Clofarabine—Tachycardia—Carmustine—malignant glioma	0.00216	0.0038	CcSEcCtD
Clofarabine—Oedema—Temozolomide—malignant glioma	0.00214	0.00376	CcSEcCtD
Clofarabine—Infection—Temozolomide—malignant glioma	0.00213	0.00374	CcSEcCtD
Clofarabine—Anorexia—Carmustine—malignant glioma	0.00211	0.00371	CcSEcCtD
Clofarabine—Nervous system disorder—Temozolomide—malignant glioma	0.0021	0.00369	CcSEcCtD
Clofarabine—Thrombocytopenia—Temozolomide—malignant glioma	0.0021	0.00368	CcSEcCtD
Clofarabine—Skin disorder—Temozolomide—malignant glioma	0.00208	0.00365	CcSEcCtD
Clofarabine—Hypotension—Carmustine—malignant glioma	0.00207	0.00364	CcSEcCtD
Clofarabine—Hyperhidrosis—Temozolomide—malignant glioma	0.00207	0.00364	CcSEcCtD
Clofarabine—Anorexia—Temozolomide—malignant glioma	0.00204	0.00358	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00202	0.00355	CcSEcCtD
Clofarabine—Paraesthesia—Carmustine—malignant glioma	0.00199	0.00349	CcSEcCtD
Clofarabine—Dyspnoea—Carmustine—malignant glioma	0.00198	0.00347	CcSEcCtD
Clofarabine—Somnolence—Carmustine—malignant glioma	0.00197	0.00346	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00195	0.00343	CcSEcCtD
Clofarabine—Decreased appetite—Carmustine—malignant glioma	0.00193	0.00338	CcSEcCtD
Clofarabine—Paraesthesia—Temozolomide—malignant glioma	0.00192	0.00338	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00191	0.00336	CcSEcCtD
Clofarabine—Dyspnoea—Temozolomide—malignant glioma	0.00191	0.00335	CcSEcCtD
Clofarabine—Somnolence—Temozolomide—malignant glioma	0.00191	0.00334	CcSEcCtD
Clofarabine—Pain—Carmustine—malignant glioma	0.0019	0.00333	CcSEcCtD
Clofarabine—Decreased appetite—Temozolomide—malignant glioma	0.00186	0.00327	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00185	0.00325	CcSEcCtD
Clofarabine—Fatigue—Temozolomide—malignant glioma	0.00185	0.00324	CcSEcCtD
Clofarabine—ABCG2—brain—malignant glioma	0.00184	0.0105	CbGeAlD
Clofarabine—Pain—Temozolomide—malignant glioma	0.00183	0.00322	CcSEcCtD
Clofarabine—Feeling abnormal—Carmustine—malignant glioma	0.00183	0.00321	CcSEcCtD
Clofarabine—Gastrointestinal pain—Carmustine—malignant glioma	0.00181	0.00318	CcSEcCtD
Clofarabine—Feeling abnormal—Temozolomide—malignant glioma	0.00177	0.0031	CcSEcCtD
Clofarabine—Abdominal pain—Carmustine—malignant glioma	0.00175	0.00308	CcSEcCtD
Clofarabine—Body temperature increased—Carmustine—malignant glioma	0.00175	0.00308	CcSEcCtD
Clofarabine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00175	0.00308	CcSEcCtD
Clofarabine—Body temperature increased—Temozolomide—malignant glioma	0.00169	0.00297	CcSEcCtD
Clofarabine—Abdominal pain—Temozolomide—malignant glioma	0.00169	0.00297	CcSEcCtD
Clofarabine—Hypersensitivity—Carmustine—malignant glioma	0.00163	0.00287	CcSEcCtD
Clofarabine—Asthenia—Carmustine—malignant glioma	0.00159	0.00279	CcSEcCtD
Clofarabine—RRM2—Fluoropyrimidine Activity—TP53—malignant glioma	0.00158	0.00654	CbGpPWpGaD
Clofarabine—Hypersensitivity—Temozolomide—malignant glioma	0.00158	0.00277	CcSEcCtD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—MDM2—malignant glioma	0.00154	0.00637	CbGpPWpGaD
Clofarabine—Asthenia—Temozolomide—malignant glioma	0.00154	0.0027	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—TOP2A—malignant glioma	0.00153	0.00636	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—RAF1—malignant glioma	0.00153	0.00635	CbGpPWpGaD
Clofarabine—Diarrhoea—Carmustine—malignant glioma	0.00152	0.00266	CcSEcCtD
Clofarabine—Pruritus—Temozolomide—malignant glioma	0.00152	0.00266	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.0015	0.00623	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—CDKN2A—malignant glioma	0.0015	0.00623	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.00149	0.00618	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—TFRC—malignant glioma	0.00149	0.00616	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.00148	0.00613	CbGpPWpGaD
Clofarabine—Dizziness—Carmustine—malignant glioma	0.00147	0.00257	CcSEcCtD
Clofarabine—Diarrhoea—Temozolomide—malignant glioma	0.00147	0.00257	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.00143	0.00591	CbGpPWpGaD
Clofarabine—POLA1—Telomere Maintenance—TERT—malignant glioma	0.00143	0.0059	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TUBG2—malignant glioma	0.00142	0.00587	CbGpPWpGaD
Clofarabine—Dizziness—Temozolomide—malignant glioma	0.00142	0.00249	CcSEcCtD
Clofarabine—Vomiting—Carmustine—malignant glioma	0.00141	0.00247	CcSEcCtD
Clofarabine—Rash—Carmustine—malignant glioma	0.0014	0.00245	CcSEcCtD
Clofarabine—Dermatitis—Carmustine—malignant glioma	0.0014	0.00245	CcSEcCtD
Clofarabine—Headache—Carmustine—malignant glioma	0.00139	0.00244	CcSEcCtD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—KDR—malignant glioma	0.00138	0.00574	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—RTEL1—malignant glioma	0.00138	0.00573	CbGpPWpGaD
Clofarabine—Vomiting—Temozolomide—malignant glioma	0.00136	0.00239	CcSEcCtD
Clofarabine—Rash—Temozolomide—malignant glioma	0.00135	0.00237	CcSEcCtD
Clofarabine—Dermatitis—Temozolomide—malignant glioma	0.00135	0.00237	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.00134	0.00556	CbGpPWpGaD
Clofarabine—Headache—Temozolomide—malignant glioma	0.00134	0.00236	CcSEcCtD
Clofarabine—Nausea—Carmustine—malignant glioma	0.00132	0.00231	CcSEcCtD
Clofarabine—DCK—Metabolism—RTEL1—malignant glioma	0.00129	0.00535	CbGpPWpGaD
Clofarabine—Nausea—Temozolomide—malignant glioma	0.00127	0.00223	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.00127	0.00526	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—MDM2—malignant glioma	0.00127	0.00525	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—RAF1—malignant glioma	0.00126	0.00523	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—MYC—malignant glioma	0.00124	0.00512	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—malignant glioma	0.00123	0.00509	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.0012	0.00497	CbGpPWpGaD
Clofarabine—POLA1—Chromosome Maintenance—TERT—malignant glioma	0.00119	0.00492	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—MDM2—malignant glioma	0.00118	0.00491	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—RAF1—malignant glioma	0.00118	0.00489	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.00116	0.00481	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDKN2B—malignant glioma	0.0011	0.00455	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.00108	0.00445	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—MYC—malignant glioma	0.00108	0.00445	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—PLK1—malignant glioma	0.00106	0.00441	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—HIST1H3B—malignant glioma	0.00105	0.00437	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.00104	0.00431	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.00103	0.00426	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—CDKN2A—malignant glioma	0.00103	0.00426	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—MYC—malignant glioma	0.00102	0.00422	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—PLK1—malignant glioma	0.000973	0.00403	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—HIST1H3B—malignant glioma	0.000964	0.00399	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—COX8A—malignant glioma	0.000964	0.00399	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—PLK1—malignant glioma	0.000952	0.00394	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—HIST1H3B—malignant glioma	0.000943	0.00391	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CDKN2A—malignant glioma	0.000919	0.00381	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000904	0.00374	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—TERT—malignant glioma	0.000891	0.00369	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—MYC—malignant glioma	0.000885	0.00367	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—malignant glioma	0.000883	0.00366	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000877	0.00363	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—MDM2—malignant glioma	0.000867	0.00359	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—RAF1—malignant glioma	0.000864	0.00358	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—HIF1A—malignant glioma	0.000852	0.00353	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.00084	0.00348	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000833	0.00345	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000832	0.00345	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—malignant glioma	0.000827	0.00343	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—TOP2A—malignant glioma	0.000823	0.00341	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.00082	0.0034	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ASMT—malignant glioma	0.00082	0.0034	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000817	0.00339	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—H3F3A—malignant glioma	0.000814	0.00337	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000809	0.00335	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—COX8A—malignant glioma	0.000794	0.00329	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000791	0.00328	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—YWHAE—malignant glioma	0.000785	0.00325	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—BCAN—malignant glioma	0.000771	0.00319	CbGpPWpGaD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—malignant glioma	0.000763	0.00316	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000757	0.00313	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—H3F3A—malignant glioma	0.000745	0.00309	CbGpPWpGaD
Clofarabine—DCK—Metabolism—COX8A—malignant glioma	0.000742	0.00307	CbGpPWpGaD
Clofarabine—RRM2—G1/S Transition—MYC—malignant glioma	0.000739	0.00306	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TOP2A—malignant glioma	0.000736	0.00305	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000734	0.00304	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—H3F3A—malignant glioma	0.000728	0.00302	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—PLK1—malignant glioma	0.000728	0.00302	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—malignant glioma	0.000727	0.00301	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—HIST1H3B—malignant glioma	0.000721	0.00299	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—YWHAE—malignant glioma	0.000702	0.00291	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—MYC—malignant glioma	0.000697	0.00289	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.00069	0.00286	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—malignant glioma	0.000679	0.00281	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000676	0.0028	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ASMT—malignant glioma	0.000675	0.0028	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—PLK1—malignant glioma	0.000651	0.0027	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—HIST1H3B—malignant glioma	0.000645	0.00267	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—BCAN—malignant glioma	0.000635	0.00263	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000634	0.00263	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ASMT—malignant glioma	0.000631	0.00261	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—malignant glioma	0.000629	0.0026	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—MYC—malignant glioma	0.000623	0.00258	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000623	0.00258	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—IDH2—malignant glioma	0.000621	0.00257	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000606	0.00251	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—malignant glioma	0.000606	0.00251	CbGpPWpGaD
Clofarabine—DCK—Metabolism—BCAN—malignant glioma	0.000593	0.00246	CbGpPWpGaD
Clofarabine—ABCG2—Fluoropyrimidine Activity—TP53—malignant glioma	0.00059	0.00245	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN2B—malignant glioma	0.00059	0.00244	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000587	0.00243	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CYP2B6—malignant glioma	0.000584	0.00242	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.00058	0.0024	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00058	0.0024	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000573	0.00237	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—TOP2A—malignant glioma	0.000563	0.00233	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000561	0.00232	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—H3F3A—malignant glioma	0.000557	0.00231	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—YWHAE—malignant glioma	0.000537	0.00222	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—IDH1—malignant glioma	0.000534	0.00221	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000534	0.00221	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—BRCA2—malignant glioma	0.000532	0.0022	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.00053	0.00219	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN2B—malignant glioma	0.000527	0.00218	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	0.000524	0.00217	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—RTEL1—malignant glioma	0.000517	0.00214	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—SPHK1—malignant glioma	0.000517	0.00214	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—IDH2—malignant glioma	0.000511	0.00212	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—BIRC5—malignant glioma	0.000509	0.00211	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000507	0.0021	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CYP2C18—malignant glioma	0.000506	0.0021	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—MYC—malignant glioma	0.000506	0.00209	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TOP2A—malignant glioma	0.000503	0.00208	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—H3F3A—malignant glioma	0.000498	0.00206	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—malignant glioma	0.000497	0.00206	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000494	0.00205	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—APOD—malignant glioma	0.000493	0.00204	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000486	0.00202	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP2B6—malignant glioma	0.000481	0.00199	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—YWHAE—malignant glioma	0.00048	0.00199	CbGpPWpGaD
Clofarabine—DCK—Metabolism—IDH2—malignant glioma	0.000478	0.00198	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000471	0.00195	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000469	0.00194	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—BIRC5—malignant glioma	0.000465	0.00193	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000462	0.00191	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.00046	0.00191	CbGpPWpGaD
Clofarabine—POLA1—S Phase—MYC—malignant glioma	0.000459	0.0019	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000455	0.00189	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—BIRC5—malignant glioma	0.000455	0.00188	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP2B6—malignant glioma	0.000449	0.00186	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	0.000449	0.00186	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000445	0.00185	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TERT—malignant glioma	0.000441	0.00183	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—IDH1—malignant glioma	0.00044	0.00182	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—MYC—malignant glioma	0.000426	0.00177	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—SPHK1—malignant glioma	0.000426	0.00176	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP2C18—malignant glioma	0.000417	0.00173	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000413	0.00171	CbGpPWpGaD
Clofarabine—DCK—Metabolism—IDH1—malignant glioma	0.000411	0.0017	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GSTT1—malignant glioma	0.000409	0.0017	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN2B—malignant glioma	0.000403	0.00167	CbGpPWpGaD
Clofarabine—DCK—Metabolism—SPHK1—malignant glioma	0.000398	0.00165	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000397	0.00165	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP2C18—malignant glioma	0.00039	0.00161	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000388	0.00161	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PTGS1—malignant glioma	0.000384	0.00159	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—BRCA2—malignant glioma	0.000364	0.00151	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN2B—malignant glioma	0.000361	0.00149	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—BCHE—malignant glioma	0.000357	0.00148	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—SLC5A5—malignant glioma	0.000352	0.00146	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000351	0.00145	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—BIRC5—malignant glioma	0.000348	0.00144	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSTT1—malignant glioma	0.000337	0.0014	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000337	0.0014	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000323	0.00134	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PTGS1—malignant glioma	0.000316	0.00131	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000316	0.00131	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSTT1—malignant glioma	0.000315	0.00131	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—BIRC5—malignant glioma	0.000311	0.00129	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN2A—malignant glioma	0.000301	0.00125	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TERT—malignant glioma	0.000301	0.00125	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000301	0.00125	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000298	0.00124	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—COX8A—malignant glioma	0.000297	0.00123	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTGS1—malignant glioma	0.000295	0.00122	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—BCHE—malignant glioma	0.000294	0.00122	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MDM2—malignant glioma	0.000292	0.00121	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—SLC5A5—malignant glioma	0.00029	0.0012	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—AKT1—malignant glioma	0.000286	0.00119	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GSTP1—malignant glioma	0.000284	0.00118	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CAT—malignant glioma	0.000276	0.00114	CbGpPWpGaD
Clofarabine—DCK—Metabolism—BCHE—malignant glioma	0.000275	0.00114	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000274	0.00114	CbGpPWpGaD
Clofarabine—DCK—Metabolism—SLC5A5—malignant glioma	0.000271	0.00112	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000265	0.0011	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—NCOR1—malignant glioma	0.000261	0.00108	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ASMT—malignant glioma	0.000252	0.00105	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000252	0.00105	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—BCAN—malignant glioma	0.000237	0.000983	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSTP1—malignant glioma	0.000234	0.000968	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000232	0.00096	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000231	0.000955	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—MYC—malignant glioma	0.000228	0.000946	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CAT—malignant glioma	0.000227	0.000942	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000224	0.000927	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000221	0.000914	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSTP1—malignant glioma	0.000218	0.000905	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—NCOR1—malignant glioma	0.000215	0.00089	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CAV1—malignant glioma	0.000213	0.000881	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CAT—malignant glioma	0.000213	0.000881	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN2A—malignant glioma	0.000206	0.000854	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MYC—malignant glioma	0.000204	0.000846	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NCOR1—malignant glioma	0.000201	0.000832	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MDM2—malignant glioma	0.0002	0.000828	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CG—malignant glioma	0.000194	0.000802	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—IDH2—malignant glioma	0.000191	0.000792	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PPARG—malignant glioma	0.000187	0.000774	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP2B6—malignant glioma	0.00018	0.000745	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CAV1—malignant glioma	0.000175	0.000725	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CD—malignant glioma	0.00017	0.000705	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TP53—malignant glioma	0.000168	0.000695	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—IDH1—malignant glioma	0.000164	0.000681	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CAV1—malignant glioma	0.000164	0.000678	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CG—malignant glioma	0.000159	0.000661	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SPHK1—malignant glioma	0.000159	0.000659	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MYC—malignant glioma	0.000156	0.000647	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP2C18—malignant glioma	0.000156	0.000646	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PPARG—malignant glioma	0.000154	0.000638	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CG—malignant glioma	0.000149	0.000617	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CB—malignant glioma	0.000148	0.000615	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PTGS2—malignant glioma	0.000147	0.000609	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PPARG—malignant glioma	0.000144	0.000596	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CD—malignant glioma	0.00014	0.000581	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MYC—malignant glioma	0.00014	0.000579	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CD—malignant glioma	0.000131	0.000543	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PTEN—malignant glioma	0.000128	0.000531	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTT1—malignant glioma	0.000126	0.000522	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CB—malignant glioma	0.000122	0.000506	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PTGS2—malignant glioma	0.000121	0.000502	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTGS1—malignant glioma	0.000118	0.00049	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TP53—malignant glioma	0.000115	0.000475	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CB—malignant glioma	0.000114	0.000473	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTGS2—malignant glioma	0.000113	0.000469	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—BCHE—malignant glioma	0.00011	0.000455	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SLC5A5—malignant glioma	0.000109	0.00045	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PTEN—malignant glioma	0.000106	0.000437	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—RAF1—malignant glioma	9.99e-05	0.000414	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTEN—malignant glioma	9.87e-05	0.000409	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CA—malignant glioma	9.05e-05	0.000375	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTP1—malignant glioma	8.74e-05	0.000362	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CAT—malignant glioma	8.51e-05	0.000352	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NCOR1—malignant glioma	8.03e-05	0.000333	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CA—malignant glioma	7.45e-05	0.000309	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—AKT1—malignant glioma	7.39e-05	0.000306	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CA—malignant glioma	6.96e-05	0.000288	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CAV1—malignant glioma	6.55e-05	0.000271	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—AKT1—malignant glioma	6.09e-05	0.000252	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CG—malignant glioma	5.96e-05	0.000247	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PPARG—malignant glioma	5.76e-05	0.000238	CbGpPWpGaD
Clofarabine—DCK—Metabolism—AKT1—malignant glioma	5.69e-05	0.000236	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CD—malignant glioma	5.24e-05	0.000217	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CB—malignant glioma	4.57e-05	0.000189	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTGS2—malignant glioma	4.53e-05	0.000188	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTEN—malignant glioma	3.95e-05	0.000164	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CA—malignant glioma	2.79e-05	0.000115	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—AKT1—malignant glioma	2.28e-05	9.43e-05	CbGpPWpGaD
